Radformation
Latest round
- Series A
Last raised
- May 2023
Total raised
- $8.4M
Investors
- 2
About Radformation
Radformation, Inc.Founded in 2016, Radformation, Inc. is headquartered in New York, US, and specializes in creating software that optimizes cancer treatment planning. The company was co-founded by Alan Nelson, Elisabeth Van Wie, and Kurt Sysock, with Kurt Sysock serving as the CEO.Radformation specializes in automation software designed for cancer treatment clinics, focusing on enhancing plan quality, safety, and operational efficiency. Their core product offerings include AutoContour, which automates the creation of deep-learning contours for radiation therapy; EZFluence, which generates high-quality 3D treatment plans; and ClearCheck, which provides one-click evaluation tools for treatment plans. Each product addresses specific challenges faced by clinics, such as the need for rapid processing of complex treatment plans and the efficient management of documentation and billing procedures. The company serves a diverse client base that includes prominent cancer treatment centers and universities worldwide, such as the University of California San Diego and the BC Cancer Agency, enabling them to streamline workflows and improve patient care.Radformation generates revenue primarily through direct sales of its software solutions to cancer treatment facilities, often structured as subscription-based models. Clients engage with the company's offerings through annual or multi-year contracts, which provide ongoing access to software updates and customer support. The pricing structure typically reflects the comprehensive nature of their flagship products, such as the automated contouring and planning software, designed to integrate seamlessly with existing treatment planning systems like Eclipse™ TPS. Revenue is influenced by the volume of transactions between Radformation and medical facilities, where clinics deploy multiple products to optimize their treatment planning workflows. The company is focused on launching new products to further enhance its offerings and aims to expand into additional geographic regions, targeting markets in Asia and Europe by late 2024. This strategic growth will help Radformation to continue improving operational efficiency for cancer clinics globally.
Who invested in Radformation
2 investors across 2 rounds
See all investors in Radformation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Radformation
Who invested in Radformation?
Radformation has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Radformation raised?
Radformation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Radformation last raise money?
Radformation's most recent round on record is a Series A, in May 2023.
What does Radformation do?
Radformation is a software company.
Where is Radformation headquartered?
Radformation is headquartered in New York, US.
Which VCs invest in companies like Radformation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Radformation's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Radformation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.